Drug intelligence / Profile preview

isopropyl alcohol + bupivacaine + dexamethasone

Development stage
Unknown
Lead developer
AstraZeneca
Modality
Small Molecules
Administration
Topical, Perineural, Intramuscular, Subcutaneous
01

Overview

A multi-component combination of **isopropyl alcohol**, **bupivacaine**, and **dexamethasone**. - **Bupivacaine** is a long-acting local anesthetic that inhibits nerve impulse transmission by blocking voltage-gated sodium channels in neuronal membranes, resulting in analgesia and anesthesia. - **Dexamethasone** is a synthetic glucocorticoid with potent anti-inflammatory, immunosuppressive, and analgesic properties; when added to bupivacaine, it significantly prolongs the duration of peripheral nerve block analgesia and reduces postoperative opioid requirements through a perineural mechanism, likely involving vasoconstriction and direct action on peripheral glucocorticoid receptors[1][2][3][4][5]. - **Isopropyl alcohol** is an antiseptic agent, generally used for skin disinfection, not for analgesic or anesthetic effect. This combination may be used in perioperative settings for local/regional anesthesia to enhance analgesia duration, minimize opioid consumption, and prevent infection. No evidence of unique combination product or branded drug formulation of all three ingredients together is identified in the literature; the combination primarily reflects off-label or compounded clinical practice.

Brand names
Marbeta L Kit
Other names
bupivacaine hydrochloride + dexamethasone sodium phosphate + isopropyl alcohol
02

Targets

NaV (Voltage-gated sodium channels)NMDAR (Glutamate receptor ionotropic, NMDA)Biological membraneGR (Glucocorticoid receptor)

Beyond the preview

Go deeper on isopropyl alcohol + bupivacaine + dexamethasone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on isopropyl alcohol + bupivacaine + dexamethasone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call